Corporate Vision May 2017

CORPORATE VISION / May 2017 7 NEWS , The decision to look for corporate sponsors to fund the provision of secure video within neonatal units will make technology, that would have previously been out of reach due to unavailable budget, accessible for the wider neonatal community. Ben Moore, founder of vCreate, explains why he believes this innovative approach to funding will make all the difference: “It’s clear from our discussions with medics that digital technology such as this has huge potential to transform the way services are delivered across the NHS. De- lays or lack of central funding can leave the people who deliver the care hamstrung; there’s a proven case for a solution, a need for change, but budget for such initi- atives isn’t readily available.” The team at vCreate is in search of corporate sponsors to fund instances of vCreate by neonatal region. With vCreate, staff are able to send short videos of babies to parents when they are away from this hospital. Ben added: “We’ve already seen how secure video is enhancing patient care following the successful pilot programme at the Royal Hospital for Children in Glasgow, and there’s been widespread media and public interest in the project.” Personalised video specialists, vCreate, recently announce a new funding initiative aimed at ensuring that all 200 UK neonatal networks are equipped with personalised video by 2018. According to Bliss, the UK’s special care baby charity; over 90,000 babies are admitted to neonatal care in the UK because they have either been born prematurely, or full termbut sick. Royal Glasgow Hospital for Children is the first in the UK to trial vCreate in their neona- tal unit. Neil Patel, Consultant Neonatologist, explains how vCreate is supporting mums and dads through what can be an ex- tremely stressful time: “The idea originally came from a parent of one of our patients. He uses personalised video in his work to connect with clients and asked if we could send him video updates of his own baby. We then asked more families who all told us there is nothing more reassuring than actually seeing their baby. It’s a personalised video platform that makes it quick and simple to create a video which can then be securely accessed by the baby’s parents on any device at any time.” vCreate believes that the funding proposition delivers for both the public and private sectors. The public-sector gains innovative video technology when they need it, and private sector sponsors have the opportunity to support families of premature babies. As part of the sponsorship package, corporate sponsors can expect to see their company logo across the vCreate application which would be seen by the par- ents logging in to watch the vide- os; plus, media coverage across multiple channels, and positive brand and CSR association. For more information, please email [email protected]. The net initial yield on the Seed Portfolio is 7.6%. with rental in- come accruing from admission on 7 March 2017, supporting the company’s div- idend policy. The company is target- ing the payment of dividends for the first 12 months from admission which equate to a yield of 6%. per annum on the Issue Price, on an ungeared basis and payable in quarterly instalments. The Seed Portfolio comprises 56 residential care homes offering 2,479 beds which are leased to the Initial Tenants, in each case, for an initial term of 20 years with an op- tion to extend for two further 10 year periods. The leases are subject to annual uplifts based on increases in the UK retail prices index (subject to a cap and floor). Further to the announcement on 2 March 2017 and following comple- tion, applications have been made for the admission of 14,000,000 Or- dinary Shares to trading on the Spe- cialist Fund Segment of main mar- ket of the London Stock Exchange in connection with the Vendor Issue. Admission is expected to occur at 8.00 a.m. on 5 May 2017. Pursuant to the Vendor Issue, Mahesh Patel has subscribed for 10,000,000 Ordinary Shares through a wholly-owned SPV, Maal Limited. Maal Limited has entered into a lock-in deed dated 3 May 2017 on equivalent terms to the lock-in deed granted by Mr. Patel on the company’s IPO. The total number of Ordinary Shares in issue immediately follow- ing Admission will be 160,172,360, each with equal voting rights. This total voting rights figure can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in the company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority. Rupert Barclay, non-executive Chair- man of Impact Healthcare REIT plc, commented: “We are pleased to have completed the acquisition of the Seed Portfolio following the IPO in March 2017. This diversified operat- ing portfolio of residential care homes is let to experienced operators for an initial term of 20 years, providing the company with stable, secure cash flows from admission. This enables the company to provide shareholders with regular, attractive, inflation-pro- tected income with the potential for dividend and capital growth through active asset management as well as potential acquisitions. Impact Healthcare is a well-re- sourced and extensively networked care home investor well placed to capitalise on the highly-fragmented market with a supply/demand imbal- ance that is continuing to grow.” Impact Healthcare Reit Plc - Acquisition of Seed Portfolio Impact Healthcare REIT plc is pleased to announce that the company has completed the acquisition of the Core Seed Portfolio and theMulberry Portfolio for a total consideration of £148,754,000. All outstanding lending facilities have been repaid in full and the Seed Portfolio has been acquired debt-free by the company. The terms of the acquisition are in accordance with the prospectus published by the company on 24 January 2017 (the “Prospectus”).